Clinical Trial to Evaluate the Efficacy and Safety of Suvaro®OD Tablet in Patients With Dyslipidemia

NCT06153433 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Dyslipidemia

Interventions

DRUG: Rosuvastatin Immediate-Release Tablet (IRT) 10mg
DRUG: Rosuvastatin orally disintegrating tablet (SUVARO®ODT) 10mg

Sponsor

Yonsei University